NeuroScientific Biopharmaceuticals Limited Stock
Equities
NSB
AU0000012973
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.051 AUD | -3.77% | -13.56% | +15.91% |
Sales 2022 | - | Sales 2023 | 4.95M 3.23M | Capitalization | 11.48M 7.48M |
---|---|---|---|---|---|
Net income 2022 | -10M -6.52M | Net income 2023 | -1M -652K | EV / Sales 2022 | - |
Net cash position 2022 | 7.22M 4.7M | Net cash position 2023 | 4.91M 3.2M | EV / Sales 2023 | 1.33 x |
P/E ratio 2022 |
-2.47
x | P/E ratio 2023 |
-10.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.16% |
1 day | -3.77% | ||
1 week | -13.56% | ||
Current month | +8.51% | ||
1 month | +13.33% | ||
3 months | +45.71% | ||
6 months | -15.00% | ||
Current year | +15.91% |
Managers | Title | Age | Since |
---|---|---|---|
Simon Scott
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-31 |
Dougal Thring
COO | Chief Operating Officer | - | 21-03-30 |
Anton Uvarov
BRD | Director/Board Member | - | 17-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anton Uvarov
BRD | Director/Board Member | - | 17-09-28 |
Chairman | - | Nov. 16 | |
Tony Keating
BRD | Director/Board Member | - | Dec. 04 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.051 | -3.77% | 113 143 |
24-04-23 | 0.053 | +1.92% | 188,602 |
24-04-22 | 0.052 | -1.89% | 67,124 |
24-04-19 | 0.053 | -10.17% | 1,432,994 |
24-04-17 | 0.059 | +1.72% | 15,000 |
Delayed Quote Australian S.E., April 23, 2024 at 11:43 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+15.91% | 4.84M | |
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |
- Stock Market
- Equities
- NSB Stock